Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAC Camargo Cancer Center

About this trial

The treatment of colorectal cancer, in the absence of metastases, is primarily based on surgical removal. Colorectal surgery, which involves resecting part of the intestine and restoring intestinal continuity, carries a risk of complications. This study aims to evaluate whether oral supplementation with a postbiotic at a dose of 900 mg for 7 days prior to surgery reduces the rate of postoperative complications.

Eligibility criteria

Qualifiers

Individuals diagnosed with malignant neoplasm of the large intestine, specifically adenocarcinoma.

Patients over 18 years of age, of both sexes.

Patients who agree to participate in the study and sign the informed consent form.

Disqualifiers

Emergency or urgent surgeries.

Cytoreductive surgeries involving intraoperative intraperitoneal chemotherapy.

Extended surgeries for the treatment of recurrent tumors.

Trial design

Treatments tested in this trial

  • Postbiotic
  • Placebo

Treatment groups

164 Participants
are divided into 2 treatment groups

Sponsors and collaborators